CAR-T cells for H3K27-altered diffuse midline gliomas: where do we stand?

Power, Erica A; Millesi, Elena; Rechberger, Julian S; Daniels, David J

Power, Erica A; Millesi, Elena; Rechberger, Julian S; Daniels, David J.

Afiliación

Power EA; Loyola University Chicago Stritch School of Medicine, Maywood, IL 60141, USA.
Millesi E; Division of Plastic & Reconstructive Surgery, Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Rechberger JS; Research Laboratory of the Division of Plastic & Reconstructive Surgery, Department of Surgery, Medical University of Vienna, Vienna 1090, Austria.
Daniels DJ; Department of Neurosurgery, Mayo Clinic, Rochester, MN 55905, USA.

Immunotherapy ; : 1-4, 2024 Jul 17.

Article en En | MEDLINE | ID: mdl-39016046

Palabras clave

B7-H3; CAR-T cell; GD2; bloodbrain barrier; diffuse midline glioma

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Immunotherapy Asunto de la revista: ALERGIA E IMUNOLOGIA / TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google